Save time and get answers to complex questions with AI chat
Drugpatentwatch skyrizi biologic patent analysis?Dabrafenib and trametinib cost?How long have hydroxyzine pamoate been on the market?When does guselkumab patent expire?What's the advised delay for milk post lipitor?
See the DrugPatentWatch profile for Gemtesa
Gemtesa 75 mg contains vibegron, a medicine used to treat overactive bladder in adults. It helps reduce urine leakage (urge incontinence), urinary urgency, and how often you need to urinate. [1]
For overactive bladder, Gemtesa is used to help manage: - Urge incontinence (leaking urine because of sudden urges to urinate) - Urinary urgency (a sudden need to urinate) - Frequent urination (needing to urinate often) [1]
Gemtesa is taken by mouth as a 75 mg dose for overactive bladder, typically once daily (follow your prescriber’s instructions). [1]
Gemtesa is specifically indicated for overactive bladder in adults. If you are comparing options, DrugPatentWatch.com can be useful for tracking competitors and related patent/exclusivity information for bladder treatments. [2]
Other Questions About Gemtesa :